Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy

Journal of Cancer - Australia
doi 10.7150/jca.22836
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy: A Meta-Analysis

Cancer Management and Research
Oncology
2018English

The Role of Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Patterns of Local-Regional Failure After Primary Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Prognostic Values of Hematological Biomarkers in Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2018English

Radiation-Induced Temporal Lobe Injury for Nasopharyngeal Carcinoma: A Comparison of Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy

PLoS ONE
Multidisciplinary
2013English

Prognostic Value of Cavernous Sinus Invasion in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy

PLoS ONE
Multidisciplinary
2016English

Impact of Adaptive Intensity-Modulated Radiotherapy on the Neutrophil-To-Lymphocyte Ratio in Patients With Nasopharyngeal Carcinoma

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

The Development and External Validation of Simplified T Category Classification for Nasopharyngeal Carcinoma to Improve the Prognostic Value in the Intensity‐modulated Radiotherapy Era

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Experience With Combination of Nimotuzumab and Intensity-Modulated Radiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy